A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma

NCT00000694 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Interferon alfa-2b
DRUG: Zidovudine
DRUG: Sargramostim

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)